CHICAGO, April 07, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the first quarter ending March 31, 2025 after market close on Thursday, May 8, 2025. The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) on Thursday, May ...

Contacts: David K. Waldman-US Investor Relations Crescendo Communications, LLC (212) 671-1021 The 11th Annual Waste & Environmental Services Symposium draws companies with a focus on the themes of waste, water treatment, and the environment. This timely conference will feature presentations by senior management of leading companies, with an emphasis on industry dynamics, new technologies, and company fundamentals. To register to attend the symposium, please follow this link. About Perma-Fix Environmental Se ...

Direct Digital Holdings, Inc. (NASDAQ:DRCT) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Corporate Participants Brett Milotte - Investor Relations, ICR Mark Walker - Chairman and Chief Executive Officer Diana Diaz - Chief Financial Officer Conference Call Participants Dan Kurnos - The Benchmark Company Michael Kupinski - NOBLE Capital Markets Operator Thank you for standing by. Welcome to the Direct Digital Holdings Fourth Quarter and Full Year 2024 Earnings Call. All lines have been placed on ...

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Andrew Funderburk - Senior Vice President, Investor Relations and Strategic Finance Markus Warmuth - Chief Executive Officer Filip Janku - Chief Medical Officer Sharon Townson - Chief Scientific Officer Phil Nickson - Chief Business and Legal Officer Conference Call Participants Kelly Shi - Jefferies Edward Tenthoff - Piper Sandler Mark Fromm - TD Cowen Robert Driscoll - Wedbush Michael ...

Financial Data and Key Metrics Changes - The company completed its 2022 restatement and is on track to become current with its filing obligations [6][8] - For 2023, estimated GAAP revenue is projected to be between $620 million and $625 million, with recurring revenue making up approximately 80% of total revenue [23][24] - Adjusted EBITDA for 2023 is estimated to be between $139 million and $144 million, which is higher than previously estimated [24] - For 2024, GAAP revenue is estimated to be between $583 million and $588 million, with a recurring revenue percentage consistent with prior years [27] - Adjusted EBITDA for 2024 is estimated to be between $85 million and $90 million, below previous guidance [29][30] Business Line Data and Key Metrics Changes - Provider business revenue dipped by 1% year-over-year, while payer and life sciences revenue declined by 10% [27][28] - The company signed significant contracts in its provider business, including a multimillion-dollar deal with a large urology practice and a major wound care organization [13][14] - The payer business saw the onboarding of nearly 400 new sites in 2025, with care gap alerts provided to over 3,500 healthcare practices [14] Market Data and Key Metrics Changes - The company experienced unexpected revenue shortfalls in the payer and life sciences segments, particularly in Q4 of 2024 [26][68] - The life sciences segment saw softness in media revenue and real-world data sales, while the payer segment faced implementation delays [68] Company Strategy and Development Direction - The company aims to remediate material weaknesses and enhance internal controls while executing its growth strategy [15][36] - The focus is on expanding the core provider base and enhancing the value of offerings, including AI-enabled workflows [15][16] - The company is pursuing additional debt financing to ensure liquidity and support future growth [80] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model despite revenue shortfalls and emphasized the importance of operational improvements [12][36] - The outlook for 2025 anticipates flat revenue compared to 2024, with expectations of growth from new customers offset by customer attrition [32][58] - Management noted that the remediation efforts and regaining current filing status are expected to occur in 2026 [33][41] Other Important Information - The company incurred significant external audit and legal fees in 2023 and 2024, impacting cash flow [9][30] - The acquisition of Science.io and Koa Health is expected to impact EBITDA margins due to new costs associated with these businesses [101][102] Q&A Session Summary Question: Clarification on remediation efforts and filing status - Management clarified that remediation efforts can continue while regaining currency on filings, with both expected to occur in 2026 [38][40] Question: Net attrition in provider business - Higher net attrition was noted in the core provider business, particularly in revenue cycle management, but not driven by market consolidation [44][46] Question: Revenue visibility for FY 2025 - Management indicated that while revenue is expected to be flat, there are uncertainties due to customer attrition and the need for a rebound from the previous year's shortfall [60][63] Question: Trends in life sciences and pharma segment - Management noted softness in media revenue but observed a pickup in spending in Q1 2025, indicating potential recovery in the life sciences segment [89] Question: Impact of acquisitions on financials - The acquisition of Science.io is not expected to contribute revenue in 2024, but it is seen as a strategic investment in AI capabilities [97][100]

Creative Realities (CREX) Q4 2024 Earnings Call March 17, 2025 09:00 AM ET Company Participants Ryan Mudd - Interim CFORick Mills - CEOGeorge Sautter - Chief Strategy Officer & Head of Corporate DevelopmentBrian Kinstlinger - MD, Director of Research & Head of Technology ResearchBen Howard - Private Equity Associate Conference Call Participants Jason Kreyer - Senior Research AnalystHoward Halpern - Principal Equity AnalystNone - Analyst Operator Good morning. At this time, I would like to welcome everyone t ...

Townsquare Media (TSQ) Q4 2024 Earnings Call March 17, 2025 08:00 AM ET Company Participants Claire Yenicay - Executive Vice President, Investor Relations and Corporate CommunicationsBill Wilson - Chief Executive OfficerStuart Rosenstein - Executive VP & CFOMichael Kupinski - Director of ResearchPatrick Sholl - Vice President Operator Good morning, and welcome to Townsquare Media's Fourth Quarter twenty twenty four Conference Call. At this time, all participants are in a listen only mode. A brief question a ...

Cardlytics (CDLX) Q4 2024 Earnings Call March 12, 2025 05:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy OfficerAmit Gupta - CEOAlexis DeSieno - Chief Financial OfficerArthur Chu - Internet Equity ResearchRobert Coolbrith - Vice President, Internet Equity Research Conference Call Participants Luke Horton - VP - Senior Equity Research AnalystKyle Peterson - Senior AnalystCal Bartyzal - Equity Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the Cardlytics Four ...

Gaia, Inc. (NASDAQ:GAIA) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ET Company Participants Jirka Rysavy - Executive Chairman James Colquhoun - Chief Executive Officer Ned Preston - Chief Financial Officer Conference Call Participants Mark Argento - Lake Street Capital Markets, LLC George Kelly - ROTH Capital Partners James Sidoti - Sidoti & Company Operator Good afternoon, and welcome to Gaia's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mod ...

Best Buy Co., Inc. (NYSE:BBY) Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ET Company Participants Mollie O'Brien - Head of Investor Relations Corie Barry - Chief Executive Officer Matt Bilunas - Chief Financial Officer Jason Bonfig - Senior Executive Vice President, Customer Offerings and Fulfillment Conference Call Participants Christopher Horvers - JPMorgan Brian Nagel - Oppenheimer Jonathan Matuszewski - Jefferies Michael Lasser - UBS Investment Bank Anthony Chukumba - Loop Capital Markets Oli ...